second subtype of senescence (Cleara Biotech)

N/A

Report date: 2025/01/26 16:52:07

Base Information

Drug Namesecond subtype of senescence (Cleara Biotech)
Drug Alias Namepeptide-based senescence chronic disease therapeutic (Cleara Biotech)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCleara Biotech BV
China Registration ClassN/A

Develop Information

Active CompaniesCleara Biotech BV
Inactive CompaniesN/A
Active Indications +[1N/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A